Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Composto B relacionado à valsartana

Composto B relacionado à valsartana is listed in the pharmaceutical impurity collection under CAS 952652-79-8. Its represented structure has formula C23H27N5O3 and a calculated molecular weight of 421.50 g/mol.

2D chemical structure

O N N N N H N O H O ( S )

Chemical identity

Catalog name
Composto B relacionado à valsartana
Common name
Composto B relacionado à valsartana
Chemical name
(2S)-2-[butanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-3-methylbutanoic acid
CAS
952652-79-8
SMILES
CCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C
InChI
InChI=1S/C23H27N5O3/c1-4-7-20(29)28(21(15(2)3)23(30)31)14-16-10-12-17(13-11-16)18-8-5-6-9-19(18)22-24-26-27-25-22/h5-6,8-13,15,21H,4,7,14H2,1-3H3,(H,30,31)(H,24,25,26,27)/t21-/m0/s1
InChIKey
OKAQHVJSXLGXET-NRFANRHFSA-N
Associated API
valsartan

Record ID: A4faab7e5da86

Computed properties

C23H27N5O3 Molecular formula
421.501 g/molMolecular weight
421.2114 DaMonoisotopic exact mass
112.07 ŲTopological polar surface area
3.7716 Calculated LogP (Wildman–Crippen)
116.7695 cm³/molMolar refractivity (Wildman–Crippen)
5 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 9 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight421.50174.01
Calculated LogP (Wildman–Crippen)3.771675.16
Topological polar surface area112.0778.33
Hydrogen-bond acceptors565.12
Hydrogen-bond donors264.87
Rotatable bonds (strict)986.25

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC23H27N5O3dimensionless
Molecular weight421.501g/mol
Monoisotopic exact mass421.2114Da
Topological polar surface area112.07Ų
Calculated LogP (Wildman–Crippen)3.7716dimensionless
Molar refractivity (Wildman–Crippen)116.7695cm³/mol
Hydrogen-bond acceptors5count
Hydrogen-bond donors2count
Rotatable bonds (strict)9count
Heavy atoms31count
Heteroatoms8count
Rings3count
Aromatic rings3count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles1count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.3478fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area180.8456Ų
Valence electrons162count
Radical electrons0count
Bertz complexity1,015.9559index
Balaban J1.8835index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Composto B relacionado à valsartana

Qualification and safety assessment of Composto B relacionado à valsartana

Explore toxicological qualification of Composto B relacionado à valsartana and ICH M7 mutagenic impurity assessment of Composto B relacionado à valsartana for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Composto B relacionado à valsartana and acceptable intake and limit justification for Composto B relacionado à valsartana. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Composto B relacionado à valsartana

Explore Altox services and software through the Altox Pharma-Hub.